Saturday, August 9, 2014

FDA Warns Compounding Pharmacy Trio With cGMP Violations

The FDA cited a trio of compounders for a wide swath of quality violations, igniting renewed criticism that the agency is “unjustified” in using a new law to enforce old violations. Read More

No comments: